Sales totaled $439 million for the third quarter, an increase of 10% from the third quarter last year and an increase of 9% at consistent currency translation rates.
Acquisitions added 1 percentage point of growth in the quarter.
Net earnings totaled $114 million for the quarter or $0.66 per diluted share.
After adjusting for the impact of excess tax benefits from stock option exercises and other non-recurring tax items, net earnings totaled $102 million or $0.59 per diluted share.
Impairment charges totaled $300,000 in the quarter and $35.2 million year-to-date.
The reported tax rate was 6% for the quarter, down 7 percentage points from last year.
On an adjusted basis, the rate in the quarter was 16% as compared to 20% in the first half of 2020.
Excluding the effect from excess tax benefits related to stock option exercises, and other one-time items, our tax rate is expected to be 18% to 19% for both the fourth quarter and the full year.
Cash flow from operations totaled $263 million year-to-date as compared to $299 million last year, primarily due to lower operating earnings and increases in working capital.
Capital expenditures totaled $46 million year-to-date as we continue to invest in manufacturing capabilities as well as the expansion of several locations.
For the full-year 2020, capital expenditures are expected to be approximately $85 million, including approximately $50 million for facility expansion projects.
On page 11 of our slide deck, we note our 6-week booking average through October 16th by segment.
At current rates, the impact would have been negligible on sales and earnings for the full year, and have a full -- have a favorable impact to the fourth quarter of approximately 2% on sales and 3% on earnings, assuming the same mix of business as the prior year.

Summary:
Net earnings totaled $114 million for the quarter or $0.66 per diluted share.
After adjusting for the impact of excess tax benefits from stock option exercises and other non-recurring tax items, net earnings totaled $102 million or $0.59 per diluted share.